Narrow your search
Listing 1 - 7 of 7
Sort by

Dissertation
The impact of phages on bacterial chromosomes : A genomics-based analysis.
Author:
Year: 2004 Publisher: Zürich : ETH (Eidgenössische Technische Hochschule),


Book
The Application of Viruses to Biotechnology
Authors: ---
Year: 2021 Publisher: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

Viruses are microscopic agents that exist worldwide and are present in humans, animals, plants, and other living organisms in which they can cause devastating diseases. However, the advances of biotechnology and next-generation sequencing technologies have accelerated novel virus discovery, identification, sequencing, and manipulation, showing that they present unique characteristics that place them as valuable tools for a wide variety of biotechnological applications. Many applications of viruses have been used for agricultural purposes, namely concerning plant breeding and plant protection. Nevertheless, it is interesting to mention that plants have also many advantages to be used in vaccine production, such as the low cost and low risks they entail, showing once more the versatility of the use of viruses in biotechnology. Although it will obviously never be ignored that viruses are responsible for devastating diseases, it is clear that the more they are studied, the more possibilities they offer to us. They are now on the front line of the most revolutionizing techniques in several fields, providing advances that would not be possible without their existence. In this book there are presented studies that demonstrate the work developed using viruses in biotechnology. These studies were brought by experts that focus on the development and applications of many viruses in several fields, such as agriculture, the pharmaceutical industry, and medicine.

Keywords

Technology: general issues --- Bacteriophage --- Salmonella --- biocontrol --- comparative genomics --- phage diversity --- grapevine --- apple latent spherical virus vector --- virus-induced flowering --- reduced generation time --- breeding of grapevine --- virus elimination --- Newcastle disease virus --- reverse genetics --- vaccines --- infectious diseases --- cancer --- porcine epidemic diarrhea virus --- VLP --- chemokines --- pig --- vaccine --- SARS-CoV-2 --- COVID-19 --- phages --- CRISPR --- viruses --- prevention --- diagnosis --- treatment --- adeno-associated virus (AAV) vector --- jaagsiekte sheep retrovirus (JSRV) --- LTR --- enhancer --- transduction --- viral vaccines --- cancers --- COVID-19 vaccines --- self-replicating RNA vectors --- DNA-based vaccines --- RNA-based vaccines --- plant virus --- viroid --- viral vector --- virus-induced gene silencing (VIGS) --- CRISPR/Cas9 --- genome editing --- carotenoid biosynthesis --- circular RNA --- infectious bursal disease virus --- immunization --- recombinant Lactococcus lactis --- variant strain --- baculovirus --- insect cells --- bacmid --- Tn7 --- genome stability --- protein expression --- chikungunya virus --- VLPs --- bioreactor --- CRISPR/Cas systems --- viral vectors --- gene editing --- plant genome engineering --- viral resistance --- adeno-associated virus --- AAV --- cancer gene therapy --- prophage --- hydrothermal vent --- Hypnocyclicus thermotrophus --- lytic cassette --- Escherichia coli --- heterologous expression --- codon optimization --- codon harmonization --- expression vectors --- aspect ratio --- VNPs --- TMV --- PVX --- CPMV --- geminivirus --- theranostics --- CRISPR-cas9 --- clodronate --- macrophage --- gene therapy --- gene expression --- nanotechnology --- Bacteriophage --- Salmonella --- biocontrol --- comparative genomics --- phage diversity --- grapevine --- apple latent spherical virus vector --- virus-induced flowering --- reduced generation time --- breeding of grapevine --- virus elimination --- Newcastle disease virus --- reverse genetics --- vaccines --- infectious diseases --- cancer --- porcine epidemic diarrhea virus --- VLP --- chemokines --- pig --- vaccine --- SARS-CoV-2 --- COVID-19 --- phages --- CRISPR --- viruses --- prevention --- diagnosis --- treatment --- adeno-associated virus (AAV) vector --- jaagsiekte sheep retrovirus (JSRV) --- LTR --- enhancer --- transduction --- viral vaccines --- cancers --- COVID-19 vaccines --- self-replicating RNA vectors --- DNA-based vaccines --- RNA-based vaccines --- plant virus --- viroid --- viral vector --- virus-induced gene silencing (VIGS) --- CRISPR/Cas9 --- genome editing --- carotenoid biosynthesis --- circular RNA --- infectious bursal disease virus --- immunization --- recombinant Lactococcus lactis --- variant strain --- baculovirus --- insect cells --- bacmid --- Tn7 --- genome stability --- protein expression --- chikungunya virus --- VLPs --- bioreactor --- CRISPR/Cas systems --- viral vectors --- gene editing --- plant genome engineering --- viral resistance --- adeno-associated virus --- AAV --- cancer gene therapy --- prophage --- hydrothermal vent --- Hypnocyclicus thermotrophus --- lytic cassette --- Escherichia coli --- heterologous expression --- codon optimization --- codon harmonization --- expression vectors --- aspect ratio --- VNPs --- TMV --- PVX --- CPMV --- geminivirus --- theranostics --- CRISPR-cas9 --- clodronate --- macrophage --- gene therapy --- gene expression --- nanotechnology


Book
Bacteriophages : Alternatives to Antibiotics and Beyond
Authors: ---
Year: 2020 Publisher: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

There is talk of an upcoming antibiotic armageddon, with untreatable post-operative infections, and similarly untreatable complications after chemotherapy. Indeed, the now famous “O’Neill Report” (https://amr-review.org/) suggests that, by 2050, more people might die from antibiotic-resistant bacterial infections than from cancer. While we are still learning all the subtle drivers of antibiotic resistance, it seems increasingly clear that we need to take a “one health” approach, curtailing the use of antibiotics in both human and veterinary medicine. However, there are no new classes of antibiotics on our horizon. Maybe something that has been around “forever” can come to our rescue—bacteriophages! Nevertheless, it is also necessary to do things differently, and use these new antimicrobials appropriately. Therefore, an in-depth study of bacteriophage biology and case-by-case applications might be required. Whilst by no means comprehensive, this book does cover some of the many topics related to bacteriophages as antimicrobials, including their use in human therapy and aquaculture. It also explores the potential use of phage endolysins as substitutes of antibiotics in two sectors where there is an urgent need—human therapy and the agro-food industry. Last but not least, there is an excellent perspective article on phage therapy implementation.

Keywords

Medicine --- bacteriophages --- dairy industry --- pathogens --- lactic acid bacteria --- fermentation failure --- biofilms --- antimicrobial resistance --- antimicrobials --- lysins --- horizontal gene transfer, transduction --- biofilm --- phage therapy --- resistance --- bacteriophage --- models --- agent based --- mass action --- bacterial phage resistance --- regression modeling --- MRSA --- Clostridium difficile --- Clostridium difficile infection --- microbiome --- in vitro fermentation model --- marine vibrios --- biological control --- aquaculture --- interactions --- vibriosis --- Aeromonas hydrophila --- Motile Aeromonas Septicemia --- MAS --- multiple-antibiotic-resistance --- striped catfish (Pangasianodon hypophthalmus) --- endolysin --- antibiotics --- one health --- protein engineering --- Aeromonas salmonicida --- furunculosis --- phage-resistant mutants --- proteins --- infrared spectroscopy --- lysin --- lytic enzyme --- peptidoglycan hydrolase --- antimicrobial --- antibacterial --- antibiotic resistance --- bacteriophage therapy --- Nagoya Protocol --- CRISPR CAS --- phage isolation --- phage resistance --- Staphylococcus --- Kayvirus --- Vibrio anguillarum --- fish larvae --- challenge trials --- phage display --- enzybiotics --- Bacteriophages --- diabetic foot ulcer --- osteomyelitis --- Staphylococcus aureus --- Antibiotic-resistant bacteria --- lysogenic conversion --- prophage induction --- read recruitment --- shiga toxin --- American Foulbrood --- phage --- Paenibacillus larvae --- Brevibacillus laterosporus --- treatment --- safety --- bystander phage therapy --- Mycobacterium smegmatis --- mycobacteriophages --- directed evolution --- PlyC CHAP --- protein net charge --- CBD-independent --- FoldX --- STEC-specific bacteriophage --- whole genome sequencing --- STEC O145 strains --- antimicrobial agent --- Pseudomonas aeruginosa --- dual-species --- antibiotic --- synergy --- simultaneous --- sequential --- microbiome therapy --- evolution --- bacteriophages --- dairy industry --- pathogens --- lactic acid bacteria --- fermentation failure --- biofilms --- antimicrobial resistance --- antimicrobials --- lysins --- horizontal gene transfer, transduction --- biofilm --- phage therapy --- resistance --- bacteriophage --- models --- agent based --- mass action --- bacterial phage resistance --- regression modeling --- MRSA --- Clostridium difficile --- Clostridium difficile infection --- microbiome --- in vitro fermentation model --- marine vibrios --- biological control --- aquaculture --- interactions --- vibriosis --- Aeromonas hydrophila --- Motile Aeromonas Septicemia --- MAS --- multiple-antibiotic-resistance --- striped catfish (Pangasianodon hypophthalmus) --- endolysin --- antibiotics --- one health --- protein engineering --- Aeromonas salmonicida --- furunculosis --- phage-resistant mutants --- proteins --- infrared spectroscopy --- lysin --- lytic enzyme --- peptidoglycan hydrolase --- antimicrobial --- antibacterial --- antibiotic resistance --- bacteriophage therapy --- Nagoya Protocol --- CRISPR CAS --- phage isolation --- phage resistance --- Staphylococcus --- Kayvirus --- Vibrio anguillarum --- fish larvae --- challenge trials --- phage display --- enzybiotics --- Bacteriophages --- diabetic foot ulcer --- osteomyelitis --- Staphylococcus aureus --- Antibiotic-resistant bacteria --- lysogenic conversion --- prophage induction --- read recruitment --- shiga toxin --- American Foulbrood --- phage --- Paenibacillus larvae --- Brevibacillus laterosporus --- treatment --- safety --- bystander phage therapy --- Mycobacterium smegmatis --- mycobacteriophages --- directed evolution --- PlyC CHAP --- protein net charge --- CBD-independent --- FoldX --- STEC-specific bacteriophage --- whole genome sequencing --- STEC O145 strains --- antimicrobial agent --- Pseudomonas aeruginosa --- dual-species --- antibiotic --- synergy --- simultaneous --- sequential --- microbiome therapy --- evolution


Book
Hurdles for Phage Therapy (PT) to Become a Reality
Author:
ISBN: 303921392X 3039213911 Year: 2019 Publisher: MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

Alternative treatment modes for antibiotic-resistant bacterial pathogens have become a public health priority. Bacteriophages are bacterial viruses that infect and lyse bacterial cells. Since bacteriophages are frequently bacterial host species-specific and can often also infect antibiotic-resistant bacterial cells, they could represent ideal antimicrobials for fighting the antibiotic resistance crisis. The medical use of bacteriophages has become known as phage therapy. It is widely used in Russia, where phage cocktails are sold in pharmacies as an over-the-counter drug. However, no phage product has been registered for medical purposes outside of the former Soviet Union. The current Special Issue of Viruses contains a collection of papers from opinion leaders in the field who explore hurdles to the introduction of phage therapy in western countries. The articles cover diverse topics ranging from patent to regulatory issues, the targeting of suitable bacterial infections, and the selection and characterization of safe and efficient phage cocktails. Phage resistance is discussed, and gaps in our knowledge of phage–bacterium interactions in the mammalian body are revealed, while other articles explore the use of phages in food production and processing.

Keywords

alginate --- abortive infection --- n/a --- bacterial resistance --- bacteriophages --- ATMP --- MALDI-MS --- adaptation --- Bacteriophage --- horizontal gene transfer --- adaptive immunity --- co-evolution --- Listeria ivanovii --- personalised medicines --- pH stability --- phage-human host interaction --- vB_SauM-fRuSau02 --- antimicrobial resistance --- phagodisinfection --- biofilm --- capsule depolymerase --- animal model --- phage cocktails --- Enterococcus --- cases report --- zoonosis --- resistance --- magistral formula --- experimental therapy --- Belgium --- phage therapy --- E. faecalis --- nontraditional antibacterial --- industrial phage application --- Democratic Republic of the Congo --- OrthoMCL --- Germany --- high-throughput sequencing --- antimicrobial --- infection --- antibiotic therapy --- Kayvirus --- phages --- Twortlikevirus --- bacterial disease --- human host --- Pseudomonas aeruginosa --- phage --- multidrug-resistant bacteria --- bacterial infection --- Salmonella Typhi --- rhamnopolysaccharide --- compassionate use --- crop production --- compounding pharmacy --- antimicrobial resistance (AMR) --- best practices --- bacteriophage efficacy --- phage sensitivity --- antibiotic-resistance --- antibiotic --- lysins --- PTMP --- Escherichia coli --- typhoid fever --- patent landscape --- phage preparation --- innate immunity --- anti-phage antibodies --- immunology --- Staphylococcus aureus --- global health --- clinical trial --- adsorption --- Brussels --- phage-resistance --- Galleria mellonella --- science communication --- history of science --- virus–host interactions --- foodborne illness --- prophage --- resistance management --- biofilms --- IND --- immunomodulation --- frequency of resistance --- capsule --- gastrointestinal tract --- phage-host interactions --- disinfection --- production --- bacteriophage therapy --- bacteriophage --- Staphylococcus --- magistral preparation --- extended-spectrum beta lactamases (ESBL) --- Viral proteins --- antibiotic resistance --- genomics --- phage biocontrol --- therapy --- target selection --- viral genomes --- evolution --- pharmaceutical paradigm shift --- personalized medicine --- pharmaceutical legislation --- food safety --- regulation --- virulence --- developing countries --- infectious disease --- regulatory framework --- sustainable agriculture --- Klebsiella pneumoniae --- virus-host interactions


Book
The Application of Viruses to Biotechnology
Authors: ---
Year: 2021 Publisher: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

Viruses are microscopic agents that exist worldwide and are present in humans, animals, plants, and other living organisms in which they can cause devastating diseases. However, the advances of biotechnology and next-generation sequencing technologies have accelerated novel virus discovery, identification, sequencing, and manipulation, showing that they present unique characteristics that place them as valuable tools for a wide variety of biotechnological applications. Many applications of viruses have been used for agricultural purposes, namely concerning plant breeding and plant protection. Nevertheless, it is interesting to mention that plants have also many advantages to be used in vaccine production, such as the low cost and low risks they entail, showing once more the versatility of the use of viruses in biotechnology. Although it will obviously never be ignored that viruses are responsible for devastating diseases, it is clear that the more they are studied, the more possibilities they offer to us. They are now on the front line of the most revolutionizing techniques in several fields, providing advances that would not be possible without their existence. In this book there are presented studies that demonstrate the work developed using viruses in biotechnology. These studies were brought by experts that focus on the development and applications of many viruses in several fields, such as agriculture, the pharmaceutical industry, and medicine.

Keywords

Technology: general issues --- Bacteriophage --- Salmonella --- biocontrol --- comparative genomics --- phage diversity --- grapevine --- apple latent spherical virus vector --- virus-induced flowering --- reduced generation time --- breeding of grapevine --- virus elimination --- Newcastle disease virus --- reverse genetics --- vaccines --- infectious diseases --- cancer --- porcine epidemic diarrhea virus --- VLP --- chemokines --- pig --- vaccine --- SARS-CoV-2 --- COVID-19 --- phages --- CRISPR --- viruses --- prevention --- diagnosis --- treatment --- adeno-associated virus (AAV) vector --- jaagsiekte sheep retrovirus (JSRV) --- LTR --- enhancer --- transduction --- viral vaccines --- cancers --- COVID-19 vaccines --- self-replicating RNA vectors --- DNA-based vaccines --- RNA-based vaccines --- plant virus --- viroid --- viral vector --- virus-induced gene silencing (VIGS) --- CRISPR/Cas9 --- genome editing --- carotenoid biosynthesis --- circular RNA --- infectious bursal disease virus --- immunization --- recombinant Lactococcus lactis --- variant strain --- baculovirus --- insect cells --- bacmid --- Tn7 --- genome stability --- protein expression --- chikungunya virus --- VLPs --- bioreactor --- CRISPR/Cas systems --- viral vectors --- gene editing --- plant genome engineering --- viral resistance --- adeno-associated virus --- AAV --- cancer gene therapy --- prophage --- hydrothermal vent --- Hypnocyclicus thermotrophus --- lytic cassette --- Escherichia coli --- heterologous expression --- codon optimization --- codon harmonization --- expression vectors --- aspect ratio --- VNPs --- TMV --- PVX --- CPMV --- geminivirus --- theranostics --- CRISPR-cas9 --- clodronate --- macrophage --- gene therapy --- gene expression --- nanotechnology


Book
Bacteriophages : Alternatives to Antibiotics and Beyond
Authors: ---
Year: 2020 Publisher: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

There is talk of an upcoming antibiotic armageddon, with untreatable post-operative infections, and similarly untreatable complications after chemotherapy. Indeed, the now famous “O’Neill Report” (https://amr-review.org/) suggests that, by 2050, more people might die from antibiotic-resistant bacterial infections than from cancer. While we are still learning all the subtle drivers of antibiotic resistance, it seems increasingly clear that we need to take a “one health” approach, curtailing the use of antibiotics in both human and veterinary medicine. However, there are no new classes of antibiotics on our horizon. Maybe something that has been around “forever” can come to our rescue—bacteriophages! Nevertheless, it is also necessary to do things differently, and use these new antimicrobials appropriately. Therefore, an in-depth study of bacteriophage biology and case-by-case applications might be required. Whilst by no means comprehensive, this book does cover some of the many topics related to bacteriophages as antimicrobials, including their use in human therapy and aquaculture. It also explores the potential use of phage endolysins as substitutes of antibiotics in two sectors where there is an urgent need—human therapy and the agro-food industry. Last but not least, there is an excellent perspective article on phage therapy implementation.

Keywords

bacteriophages --- dairy industry --- pathogens --- lactic acid bacteria --- fermentation failure --- biofilms --- antimicrobial resistance --- antimicrobials --- lysins --- horizontal gene transfer, transduction --- biofilm --- phage therapy --- resistance --- bacteriophage --- models --- agent based --- mass action --- bacterial phage resistance --- regression modeling --- MRSA --- Clostridium difficile --- Clostridium difficile infection --- microbiome --- in vitro fermentation model --- marine vibrios --- biological control --- aquaculture --- interactions --- vibriosis --- Aeromonas hydrophila --- Motile Aeromonas Septicemia --- MAS --- multiple-antibiotic-resistance --- striped catfish (Pangasianodon hypophthalmus) --- endolysin --- antibiotics --- one health --- protein engineering --- Aeromonas salmonicida --- furunculosis --- phage-resistant mutants --- proteins --- infrared spectroscopy --- lysin --- lytic enzyme --- peptidoglycan hydrolase --- antimicrobial --- antibacterial --- antibiotic resistance --- bacteriophage therapy --- Nagoya Protocol --- CRISPR CAS --- phage isolation --- phage resistance --- Staphylococcus --- Kayvirus --- Vibrio anguillarum --- fish larvae --- challenge trials --- phage display --- enzybiotics --- Bacteriophages --- diabetic foot ulcer --- osteomyelitis --- Staphylococcus aureus --- Antibiotic-resistant bacteria --- lysogenic conversion --- prophage induction --- read recruitment --- shiga toxin --- American Foulbrood --- phage --- Paenibacillus larvae --- Brevibacillus laterosporus --- treatment --- safety --- bystander phage therapy --- Mycobacterium smegmatis --- mycobacteriophages --- directed evolution --- PlyC CHAP --- protein net charge --- CBD-independent --- FoldX --- STEC-specific bacteriophage --- whole genome sequencing --- STEC O145 strains --- antimicrobial agent --- Pseudomonas aeruginosa --- dual-species --- antibiotic --- synergy --- simultaneous --- sequential --- microbiome therapy --- evolution


Book
The Application of Viruses to Biotechnology
Authors: ---
Year: 2021 Publisher: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

Viruses are microscopic agents that exist worldwide and are present in humans, animals, plants, and other living organisms in which they can cause devastating diseases. However, the advances of biotechnology and next-generation sequencing technologies have accelerated novel virus discovery, identification, sequencing, and manipulation, showing that they present unique characteristics that place them as valuable tools for a wide variety of biotechnological applications. Many applications of viruses have been used for agricultural purposes, namely concerning plant breeding and plant protection. Nevertheless, it is interesting to mention that plants have also many advantages to be used in vaccine production, such as the low cost and low risks they entail, showing once more the versatility of the use of viruses in biotechnology. Although it will obviously never be ignored that viruses are responsible for devastating diseases, it is clear that the more they are studied, the more possibilities they offer to us. They are now on the front line of the most revolutionizing techniques in several fields, providing advances that would not be possible without their existence. In this book there are presented studies that demonstrate the work developed using viruses in biotechnology. These studies were brought by experts that focus on the development and applications of many viruses in several fields, such as agriculture, the pharmaceutical industry, and medicine.

Keywords

Bacteriophage --- Salmonella --- biocontrol --- comparative genomics --- phage diversity --- grapevine --- apple latent spherical virus vector --- virus-induced flowering --- reduced generation time --- breeding of grapevine --- virus elimination --- Newcastle disease virus --- reverse genetics --- vaccines --- infectious diseases --- cancer --- porcine epidemic diarrhea virus --- VLP --- chemokines --- pig --- vaccine --- SARS-CoV-2 --- COVID-19 --- phages --- CRISPR --- viruses --- prevention --- diagnosis --- treatment --- adeno-associated virus (AAV) vector --- jaagsiekte sheep retrovirus (JSRV) --- LTR --- enhancer --- transduction --- viral vaccines --- cancers --- COVID-19 vaccines --- self-replicating RNA vectors --- DNA-based vaccines --- RNA-based vaccines --- plant virus --- viroid --- viral vector --- virus-induced gene silencing (VIGS) --- CRISPR/Cas9 --- genome editing --- carotenoid biosynthesis --- circular RNA --- infectious bursal disease virus --- immunization --- recombinant Lactococcus lactis --- variant strain --- baculovirus --- insect cells --- bacmid --- Tn7 --- genome stability --- protein expression --- chikungunya virus --- VLPs --- bioreactor --- CRISPR/Cas systems --- viral vectors --- gene editing --- plant genome engineering --- viral resistance --- adeno-associated virus --- AAV --- cancer gene therapy --- prophage --- hydrothermal vent --- Hypnocyclicus thermotrophus --- lytic cassette --- Escherichia coli --- heterologous expression --- codon optimization --- codon harmonization --- expression vectors --- aspect ratio --- VNPs --- TMV --- PVX --- CPMV --- geminivirus --- theranostics --- CRISPR-cas9 --- clodronate --- macrophage --- gene therapy --- gene expression --- nanotechnology

Listing 1 - 7 of 7
Sort by